Home - Products - GPCR/G Protein - Prostaglandin Receptor - Isbogrel

Isbogrel

CAS No. 89667-40-3

Isbogrel( —— )

Catalog No. M34289 CAS No. 89667-40-3

Isbogrel (CV4151) is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor that can be used to study cardiac arrhythmias, transient ischemic attacks and thrombosis.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	532	Get Quote
5MG	787	Get Quote
10MG	1074	Get Quote
25MG	1463	Get Quote
50MG	1822	Get Quote
100MG	2250	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Isbogrel
Note

Research use only, not for human use.
Brief Description

Isbogrel (CV4151) is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor that can be used to study cardiac arrhythmias, transient ischemic attacks and thrombosis.
Description

Isbogrel (CV4151) is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor that can be used to study cardiac arrhythmias, transient ischemic attacks and thrombosis.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

GPCR/G Protein
Target

Prostaglandin Receptor
Recptor

Prostaglandin Receptor
Research Area

——
Indication

——

Chemical Information

CAS Number

89667-40-3
Formula Weight

281.35
Molecular Formula

C18H19NO2
Purity

>98% (HPLC)
Solubility

——
SMILES

C(=C\CCCCC(O)=O)(\C1=CC=CC=C1)/C=2C=CC=NC2
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Grapiprant

A novel EP4 antagonist; an analgesic and anti-inflammatory drug in the piprant class that was approved for Veterinary Medicine for the control of pain and inflammation.
Fevipiprant

A slowly dissociating CRTh2 antagonist with Kd of 1.14 nM.
EP2 receptor antagon...

EP2 receptor antagonist-2 (CID891729) is a compound that blocks EP2 receptor activation by PGE2 and reduces lactate dehydrogenase (LDH) release induced by N-methyl-D-aspartate (NMDA).

Sign In Join Free